Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Kidney Int. 2017 Mar 6;92(1):201–213. doi: 10.1016/j.kint.2016.12.024

Table 3.

Clinical variables predicting the development of dnDSA at 24 months.

Variables predicting dnDSA Univariate analysis Multivariate analysis
OR CI 95% p value OR CI 95% p value
Post-transplant d-sp IFN-γ ELISPOT (NEG) 0.128 0.015-0.99 0.049 0.085 0.008-0.862 0.037
Induction type rATG (no) 0.356 0.077-1.642 0.192 0.154 0.023-1.005 0.051
Clinical BPAR (no) 0.413 0.074-2.303 0.314 0.430 0.046-4.062 0.462
6-month sc-TCMR 0.456 0.082-2.524 0.372 1.126 0.145-8.743 0.916
DGF 0.765 0.171-3.427 0.739 0.913 0.173-4.823 0.918
HLA mismatch 1.387 0.693-2.775 0.366
Eplet HLA AB mismatch 1.055 0.931-1.195 0.404
Eplet HLA DRB1 and DQA/B mismatch 1.013 0.951-1.079 0.688
Donor Age 0.994 0.947-1.043 0.798
Donor type (L/D) 1.200 0.227-6.334 0.831
Time HD (months) 1.002 0.981-1.024 0.854

BPAR, biopsy proved acute rejection; D, deceased; DGF, delayed graft function; dnDSA, de novo donor-specific antibodies; HD, hemodialysis; L, living; NEG, negative ELISPOT; rATG, rabbit anti-thymoglobulin. Data is presented as Mean±SD. ‘p’ values for binary logistic regression.